848358-06-5 Usage
Molecular Weight
163.22 g/mol The molecular weight is the mass of one mole of the compound.
Structure
Thieno[3,2-c]pyrazole with a methanol group at the 5th position The structure refers to the arrangement of atoms in the compound.
Heterocyclic compound
Containing a thieno and pyrazole ring A heterocyclic compound is a compound that contains a ring of atoms with at least one ring member being a different element than carbon.
Substitution
Methanol group at the 5th position The substitution refers to the replacement of a hydrogen atom in the ring with a methanol group.
Pharmacological properties
Potential use in the treatment of various medical conditions The pharmacological properties refer to the potential therapeutic effects of the compound.
Hazards
Handle with care and follow safety guidelines The hazards refer to the potential risks associated with handling the compound.
Check Digit Verification of cas no
The CAS Registry Mumber 848358-06-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,3,5 and 8 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 848358-06:
(8*8)+(7*4)+(6*8)+(5*3)+(4*5)+(3*8)+(2*0)+(1*6)=205
205 % 10 = 5
So 848358-06-5 is a valid CAS Registry Number.
848358-06-5Relevant articles and documents
COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS
-
Paragraph 0634, (2017/03/14)
Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I" and I'" or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.
CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR
-
, (2012/10/08)
Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
THIENOPYRAZOLES
-
Page/Page column 116-118, (2008/06/13)
Thienopyrazoles, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical uses in the treatment of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK).
